Abeona Therapeutics Inc vs Gigacloud Technology Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Gigacloud Technology Inc trades at $51 (market cap $1.84B). The key difference: Gigacloud Technology Inc is far larger — about 4.4× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Gigacloud Technology Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | GCT | |
|---|---|---|
Market Cap | $421.19M | $1.84B |
Sector | Health | Technology |
52-Week High | $7.45 | $53.25 |
52-Week Low | $4.17 | $25.44 |
Enterprise Value | $276.10M | $1.97B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →